Compliance

The core of our being

Compliance

Regulations. By Design.

Encapsia is designed on a basis of industry leading expertise and knowledge of world-wide regulatory requirements relating to the use of eClinical, eSource and cloud-based clinical data systems.

This expertise is the foundation of each encapsia component and is woven throughout the software development lifecycle to ensure key regulations including Food and Drugs Administration 21 (FDA 21), Code of Federal Regulation 11 (CFR 11), Good Clinical Practice (GCP) E6(R2), General Data Protection Regulation (GDPR), Health Insurance Portability and Accountability Act (HIPAA) and Data Integrity are fully and demonstrably supported.

Security. Best in class.

Information security is assured by use of top-tier, ISO27001 certified cloud hosting centres in customer definable geographies. This ensures support of both international and local data protection and privacy laws (‘Privacy by Design’) for any study.

Best in class security technology is employed throughout development and deployment including penetration testing, vulnerability and code scanning, robustly managed through specific governance processes.

This, combined with the highly qualified and experienced technical staff result in a clinical data system that conforms to the most exacting of international regulatory standards.

Compliance
Compliance

Encapsia frees you to take advantage of new paradigms of trial management to increase your team’s efficiency and profitability, without compliance concerns.

Latest articles

Delayed Clinical Data and Its Impact

The increasing complexity of modern trials demands more intensive data capture. Innovative study designs seek to minimize patient exposure to potential risks, improve convenience and shorten therapy time-to-market —requiring collecting and assimilating more data points than ever before. Data now…

Read article

Five benefits of virtual clinical trials

Clinical trials are slow, costly, and inefficient. Different studies put the average cost of drug development at $1.3 to $2.8 billion— with clinical trials accounting for about two-thirds.  Traditional trials burden patients with financial and time-costly travel requirements. On average,…

Read article

Clinical trial platform provider encapsia welcomes new COO

Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years of expertise to the role, specializing in the management of data-related projects in clinical trials…

Read article